Trial intelligence / Profile preview

Piroxicam for Perioperative Analgesia in Maxillofacial Fracture Fixation

NCT04062591Phase 1Completed

Sponsor
Ain Shams University
Start
Aug 2019
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in postoperative pain comparing Piroxicam Group with Placebo Group (2 arms). Primary endpoint: Rescue dose of analgesic at 24 hours. Started Aug 2019; status: completed.

02

Drugs

piroxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04062591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04062591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call